Tilray Brands’ subsidiary, Tilray Medical, has launched Redecan-branded medical cannabis in Australia. The subsidiary is offering two EU-GMP-certified products under the iconic Canadian brand to patients in The Land Down Under.
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | High Tide reports record revenue of $131.7 million in its Q3 2024 financial results
2 | Aurora Cannabis advances auto-flowering research, unveiling insights for future cultivation
3 | Lifeist closes CannMart transaction with Simply Solventless Concentrates
Top Cannabis Stocks Sept. 03 to Sept. 19, 2024
1. T.TLRY | 9,175 views | Tilray Brands Inc.
2. T.WEED | 4,778 views | Canopy Growth Corp.
3. C.CURA | 3,713 views | Curaleaf Holdings Inc.
4. T.LABS | 2,227 views | Medipharm Labs Corp.
5. C.OILS | 1,221 views | Nextleaf Solutions Ltd.
6. T.OGI | 717 views | OrganiGram Holdings Inc.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
